Global Economic Intersection
Advertisement
  • Home
  • Economics
  • Finance
  • Politics
  • Investments
    • Invest in Amazon $250
  • Cryptocurrency
    • Best Bitcoin Accounts
    • Bitcoin Robot
      • Quantum AI
      • Bitcoin Era
      • Bitcoin Aussie System
      • Bitcoin Profit
      • Bitcoin Code
      • eKrona Cryptocurrency
      • Bitcoin Up
      • Bitcoin Prime
      • Yuan Pay Group
      • Immediate Profit
      • BitIQ
      • BitQH
      • Bitcoin Loophole
      • Crypto Boom
      • Bitcoin Treasure
      • Bitcoin Lucro
      • Bitcoin System
      • Oil Profit
      • The News Spy
      • Bitcoin Buyer
      • Bitcoin Inform
      • Immediate Edge
      • Bitcoin Evolution
      • Cryptohopper
      • Ethereum Trader
      • BitQL
      • Quantum Code
      • Bitcoin Revolution
      • British Trade Platform
      • British Bitcoin Profit
    • Bitcoin Reddit
    • Celebrities
      • Dr. Chris Brown Bitcoin
      • Teeka Tiwari Bitcoin
      • Russell Brand Bitcoin
      • Holly Willoughby Bitcoin
No Result
View All Result
  • Home
  • Economics
  • Finance
  • Politics
  • Investments
    • Invest in Amazon $250
  • Cryptocurrency
    • Best Bitcoin Accounts
    • Bitcoin Robot
      • Quantum AI
      • Bitcoin Era
      • Bitcoin Aussie System
      • Bitcoin Profit
      • Bitcoin Code
      • eKrona Cryptocurrency
      • Bitcoin Up
      • Bitcoin Prime
      • Yuan Pay Group
      • Immediate Profit
      • BitIQ
      • BitQH
      • Bitcoin Loophole
      • Crypto Boom
      • Bitcoin Treasure
      • Bitcoin Lucro
      • Bitcoin System
      • Oil Profit
      • The News Spy
      • Bitcoin Buyer
      • Bitcoin Inform
      • Immediate Edge
      • Bitcoin Evolution
      • Cryptohopper
      • Ethereum Trader
      • BitQL
      • Quantum Code
      • Bitcoin Revolution
      • British Trade Platform
      • British Bitcoin Profit
    • Bitcoin Reddit
    • Celebrities
      • Dr. Chris Brown Bitcoin
      • Teeka Tiwari Bitcoin
      • Russell Brand Bitcoin
      • Holly Willoughby Bitcoin
No Result
View All Result
Global Economic Intersection
No Result
View All Result

As Digestive Disorders Rise, Small Caps Take Charge

admin by admin
October 21, 2013
in Uncategorized
0
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Written by Allen Caron

While many people deal with minor digestive troubles from time to time, more than 60 million people in the US live with more chronic digestive diseases. Millions of people are hospitalized each year as a result of these conditions, which range from Irritable Bowel Syndrome (IBS) to chronic constipation. Some gastrointestinal diseases can be addressed with lifestyle changes, but not all.

tummy-ache-allen-caron-320x180

Not only are gastrointestinal diseases threatening to individuals’ health, they can also pose a challenge for the economy. In Canada, the economic impact just from IBS patients missing work is estimated to be more than $6.5 billion per year. Other, more serious or chronic conditions may impact the economy even further – for example, in 2004, the economic impact of digestive diseases overall on the US economy was $141.8 billion.

IBS and other gastrointestinal conditions are also big business for pharmaceuticals companies. As author Bill Flook put it,

“IBS is a hot niche: The overall market for IBS drugs is expected to grow at a 14 percent annual rate through 2019, according to pharmaceutical research company Decision Resources Inc.”

Many small cap companies are now working to develop solutions for digestive and gastrointestinal diseases.

One such company, Ventrus Biosciences Inc (Nasdaq:VTUS), based in New York, NY, is currently undergoing late-stage trials for two potential products: VEN 307 and VEN 308, both topical treatments for various digestive issues. VEN 307, diltiazem cream, is a treatment to help relieve pain for patients with anal fissures. The company estimates that there are up to 4.3 million cases of anal fissures in the US. While diltiazem cream is a common treatment for anal fissure pain, it must be specially mixed for each patient. VEN 307 is currently undergoing Phase III trials. VEN 308, a phenylephrine gel, helps to treat fecal incontinence associated with ileal pouch anal anastomosis (IPAA), a surgical procedure that’s part of a colectomy. This topical treatment aims to help IPAA patients with fecal incontinence to improve their sphincter control. The treatment is currently undergoing PhaseII trials. VTUS closed October 7th at $3.23, down $0.10, with a market cap of $58.62 million. Its 52-week trading range is $1.91 – $3.92.

New York City, NY-based Synergy Pharmaceuticals Inc (Nasdaq:SGYP) is currently developing products to treat chronic ideopathic constipation (CIC), IBS and inflammatory bowel disease (IBD) along with additional gastrointestinal conditions. One such drug, Plecanatide (SP-304) is currently undergoing Phase II trials for an IBS-C indication, and Phase III trials for a CIC indication. This oral drug mimics the functions of uroguanylin, a gastrointestinal hormone found in humans. The company is also undergoing Phase II trials for SP-333 with an indication for IBD. Synergy recently created a new subsidiary, ContraVir Pharmaceuticals Inc, to hold the company’s FV-100 assets. Earlier this year, the company completed a merger with Callisto Pharmaceuticals, Inc, a company that developed therapeutics for cancer. SGYP closed October 7th at $4.41, up $0.01, with a market cap of $380.57 million. Its 52-week trading range is $2.98 – $7.44.

Sucampo Pharmaceuticals Inc (Nasdaq:SCMP), based in Bethesda, MD, develops treatments for a range of conditions, including gastrointestinal diseases. The company markets lubiprostone under the trade name Amitiza. The oral drug is a treatment for CIC and opioid-induced constipation (OIC, or constipation from opiate-based pain medications), as well as IBS with constipation. Sucampo partners with Takeda Pharmaceutical Co Ltd to market Amitiza, though the company lost arbitration to sever ties with the Japanese company last year – a move which caused their stock to drop 25%. SCMP closed October 7th at $6.38, up $0.10, with a market cap of $266.71 million. Its 52-week trading range is $4.41 – $10.48

As awareness for IBS and other gastrointestinal diseases continues to grow, there may be a market opportunity for small caps and other companies to develop new marketable treatments. Doctors and patients who are better informed about gastrointestinal diseases could create a savvy new market for gastrointestinal pharmaceuticals. Health care investors may be interested in keeping an eye on this specific sector to find opportunities. New breakthroughs in pharmaceutical treatments for all types of digestive disorders could not only provide new treatment options for the patients who need them, but also present a significant opportunity for investors.

Previous Post

Japan: Export Growth Rate is Faltering

Next Post

Long Island Back on Track after Sandy

Related Posts

Weaker Dollar Keeps Bitcoin Above $30K As Analysts Target 60% BTC Dominance
Economics

Weaker Dollar Keeps Bitcoin Above $30K As Analysts Target 60% BTC Dominance

by John Wanguba
May 20, 2022
Ethereum Developers Tip The Merge Might Happen In August ‘If All Goes As Planned’
Business

Ethereum Developers Tip The Merge Might Happen In August ‘If All Goes As Planned’

by John Wanguba
May 20, 2022
Commonwealth Bank Puts Crypto Trading Test On Ice As Regulators Hesitate
Business

Commonwealth Bank Puts Crypto Trading Test On Ice As Regulators Hesitate

by John Wanguba
May 20, 2022
Musk Hints He Could Reprice Twitter Deal As He Looks At Fake Accounts
Business

Musk Hints He Could Reprice Twitter Deal As He Looks At Fake Accounts

by John Wanguba
May 18, 2022
Madonna Joins Hands With Digital Artist “Beeple” To Launch New NFTs
Business

Madonna Joins Hands With Digital Artist “Beeple” To Launch New NFTs

by John Wanguba
May 18, 2022
Next Post

Long Island Back on Track after Sandy

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Browse by Category

  • Business
  • Econ Intersect News
  • Economics
  • Finance
  • Politics
  • Uncategorized

Browse by Tags

adoption altcoins banking Binance Bitcoin Bitcoin adoption Bitcoin market Bitcoin mining blockchain BTC business Coinbase crypto crypto adoption cryptocurrency crypto exchange crypto market crypto regulation decentralized finance DeFi digital assets Elon Musk ETH Ethereum Ethereum blockchain finance funding government investment market analysis Metaverse mining NFT NFT marketplace NFTs nonfungible tokens nonfungible tokens (NFTs) price analysis regulation Russia social media technology Tesla the US Twitter

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • August 2010
  • August 2009

Categories

  • Business
  • Econ Intersect News
  • Economics
  • Finance
  • Politics
  • Uncategorized
Global Economic Intersection

After nearly 11 years of 24/7/365 operation, Global Economic Intersection co-founders Steven Hansen and John Lounsbury are retiring. The new owner, a global media company in London, is in the process of completing the set-up of Global Economic Intersection files in their system and publishing platform. The official website ownership transfer took place on 24 August.

Categories

  • Business
  • Econ Intersect News
  • Economics
  • Finance
  • Politics
  • Uncategorized

Recent Posts

  • Weaker Dollar Keeps Bitcoin Above $30K As Analysts Target 60% BTC Dominance
  • Ethereum Developers Tip The Merge Might Happen In August ‘If All Goes As Planned’
  • Commonwealth Bank Puts Crypto Trading Test On Ice As Regulators Hesitate

© Copyright 2021 EconIntersect - Economic news, analysis and opinion.

No Result
View All Result
  • Home
  • Contact Us
  • Bitcoin Robot
    • Bitcoin Profit
    • Bitcoin Code
    • Quantum AI
    • eKrona Cryptocurrency
    • Bitcoin Up
    • Bitcoin Prime
    • Yuan Pay Group
    • Immediate Profit
    • BitIQ
    • Bitcoin Loophole
    • Crypto Boom
    • Bitcoin Era
    • Bitcoin Treasure
    • Bitcoin Lucro
    • Bitcoin System
    • Oil Profit
    • The News Spy
    • British Bitcoin Profit
    • Bitcoin Trader
  • Bitcoin Reddit

© Copyright 2021 EconIntersect - Economic news, analysis and opinion.

en English
ar Arabicbg Bulgarianda Danishnl Dutchen Englishfi Finnishfr Frenchde Germanel Greekit Italianja Japaneselv Latvianno Norwegianpl Polishpt Portuguesero Romanianes Spanishsv Swedish